The *State of Drug Diversion* survey uncovers serious gaps in drug diversion detection across healthcare organisations and emphasises the urgent need for AI technology and collaboration among departments to tackle this persistent problem.
Key Points
- 81% of healthcare leaders believe drug diversion is an ongoing issue, with many incidents unreported.
- Only one-third of surveyed leaders express confidence in their program’s effectiveness against diversion.
- Despite investments in training, many hospitals lack cohesive strategies to detect and prevent drug diversion.
- Current reliance on manual audits increases the risk of unnoticed diversions; 76% seek to integrate advanced analytics.
- Departments like anaesthesiology are often underrepresented in drug diversion strategies, despite their critical role.
Why should I read this?
If you’re working in healthcare or keeping a close eye on industry trends, this article is a must-read! It shines a light on a crucial challenge many hospitals face but often ignore—drug diversion. The insights from the survey can help you understand the pressing need for better technologies and collaboration to ensure patient safety and tackle this “elephant in the room” situation. Don’t miss the chance to share in this conversation and learn how organisations can improve their strategies.
